Active Ingredient: BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
Proprietary Name: PYLERA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 140MG;125MG;125MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N050786
Product Number: 001
Approval Date: Sep 28, 2006
Applicant Holder Full Name: LABORATOIRES JUVISE PHARMACEUTICALS
Marketing Status:
Prescription
Patent and Exclusivity Information